Morphic Holding, Inc.
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF…
Biotechnology
US, Waltham [HQ]
MORF/Financial Reporting
Income Statements
Profit & Loss · 7 Statements · From 2023 to 2017Configuration
In Million USD. Margins, Growth Rates In %
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | - - | 3.00 | 16.00 | 44.00 | 19.00 | 70.00 | - - | |
|
EPS
|
-1.27 | -1.04 | -1.44 | -1.47 | -2.63 | -1.55 | -3.59 | |
| Diluted in mil. | -1.27 | -1.04 | -1.44 | -1.47 | -2.63 | -1.55 | -3.59 | |
|
Profit
|
- - | 3.00 | -36.00 | -28.00 | 18.00 | 69.00 | - - | |
| Gross Margin | - - | 100.00 | -216.50 | -63.82 | 94.80 | 98.58 | -109.40 | |
| Pre Tax | -16.00 | -23.00 | -42.00 | -45.00 | -95.00 | -58.00 | -151.00 | |
| Profit Margin | - - | -709.68 | -249.84 | -101.39 | -482.68 | -83.29 | -29,119.96 | |
| ETR | 0.08 | -3.34 | -2.15 | 1.25 | 1.36 | -0.11 | -0.25 | |
| Net | -16.00 | -23.00 | -43.00 | -44.00 | -94.00 | -59.00 | -152.00 | |
| Profit Margin | - - | -709.68 | -255.22 | -100.12 | -476.10 | -83.38 | -29,192.90 | |
| EBITDA | -16.00 | -24.00 | -46.00 | -47.00 | -95.00 | -63.00 | -177.00 | |
| EBITDA Margin | - - | -717.36 | -271.94 | -104.97 | -484.02 | -89.53 | -34,087.33 | |
| Operating Income | -16.00 | -24.00 | -46.00 | -47.00 | -95.00 | -63.00 | -178.00 | |
| Operating Margin | - - | -733.41 | -276.77 | -104.97 | -484.02 | -89.53 | -34,296.74 | |
| Interest Income | - - | - - | 4.00 | 1.00 | - - | 4.00 | 26.00 | |
| Loss | -16.00 | -27.00 | -63.00 | -92.00 | -115.00 | -134.00 | -179.00 | |
| Cost of Revenue | - - | - - | -53.00 | -73.00 | -1.00 | -1.00 | -1.00 | |
|
Operating Expenses
|
-16.00 | -27.00 | -63.00 | -92.00 | -115.00 | -134.00 | -179.00 | |
| R&D | -14.00 | -22.00 | -53.00 | -73.00 | -87.00 | -102.00 | -140.00 | |
| G&A | -2.00 | -5.00 | -10.00 | -18.00 | -27.00 | -32.00 | -38.00 | |
| SG&A | -2.00 | -5.00 | -10.00 | -18.00 | -27.00 | -32.00 | -38.00 | |
| S&M | - - | - - | - - | - - | - - | - - | - - | |
| Depreciation and Amortization | - - | - - | - - | -1.00 | -1.00 | -1.00 | -1.00 | |
| Interest Expenses | - - | - - | - - | - - | - - | -4.00 | - - | |
| Other Expenses | - - | - - | -4.00 | -1.00 | - - | -4.00 | - - | |
|
WA Shares Outstanding
|
22.00 | 22.00 | 30.00 | 30.00 | 35.00 | 38.00 | 42.00 | |
| Diluted | 22.00 | 22.00 | 30.00 | 30.00 | 35.00 | 38.00 | 42.00 |